Sang Hoon Ahn Trials - LARVOL Sigma

Sang Hoon Ahn	Welcome, Profile Billing Logout

38 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ahn, Sang Hoon

LONGHEAD, NCT03042520: Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Recruiting

N/A

200

RoW

Observation only

Kaohsiung Medical University Chung-Ho Memorial Hospital, Chang Gung Memorial Hospital, National Taiwan University Hospital, National Cheng-Kung University Hospital, Chi Mei Medical Hospital, China Medical University, China, Mackay Memorial Hospital, Taipei Veterans General Hospital, Taiwan, Changhua Christian Hospital, Pusan National University Hospital, Asan Medical Center, Korea University, Inje University, Korea University Guro Hospital, Kyungpook National University Hospital, Seoul National University Hospital, Severance Hospital, Samsung Medical Center, Seoul National University Bundang Hospital, Soon Chun Hyang University, Seoul St. Mary's Hospital, Gachon University Gil Medical Center, Dong-A University Hospital, Gangnam Severance Hospital

Liver Fibroses, HepatoCellular Carcinoma, Cryoglobulinemia, Metabolic Disease, Diabetes Mellitus

09/22

NCT04139850: The Establishment of Korean Hepatitis B Patients Cohort

Recruiting

N/A

2000

RoW

Discontinuation of antiviral treatment in chronic hepatitis B cohort patients

Yonsei University

Chronic Hepatitis B

08/26

Kim, Do Young

BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting

595

Europe, Canada, Japan, US, RoW

Baricitinib, LY3009104, Placebo

Eli Lilly and Company

Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical

09/27

08/29

NCT05808335: A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

Recruiting

RoW

Standard of care

ImmuneMed, Inc.

Chronic Hepatitis B

03/24

12/24

NCT05908916: Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Not yet recruiting

RoW

AtezoBev with combined radiotherapy

Yonsei University

Hepatocellular Carcinoma

07/25

07/26

IDADOX, NCT06114082: TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

Recruiting

128

RoW

IDA-TACE, Conventional TACE using idarubicin chemoemulsion, DOX-TACE, Conventional TACE using doxorubicin chemoemulsion

Seoul National University Hospital, Guerbet

Hepatocellular Carcinoma, Liver Cancer

12/25

06/26

MIV-818-101, NCT03781934 / 2018-000995-14: A Study to Evaluate MIV-818 in Patients with Liver Cancer Manifestations

Active, not recruiting

1/2

Europe, RoW

MIV-818 (fostroxacitabine bralpamide) + pembrolizumab, MIV-818 (fostroxacitabine bralpamide) + lenvatinib

Medivir

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

01/25

06/25

NCT06712108: Observational Study of Double Cord Blood Transplant

Recruiting

N/A

RoW

tranplant

Seoul National University Hospital

Adult Double Unit Cord Blood Transplant

03/30

HOMECARE, NCT05636384: SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

Recruiting

N/A

396

RoW

Home-based care

Seoul National University Hospital, Chung-Ang University Hosptial, Chung-Ang University College of Medicine, DongGuk University, Kyung Hee University Hospital, Bundang CHA Hospital, Seoul National University Bundang Hospital

Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization

12/26

Kim, Seung Up

NCT04584242: Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Recruiting

RoW

gluconon tab 15mg, suganon tab 5mg

Yonsei University

Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

05/22

NCT05473806: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Active, not recruiting

RoW

Pioglitazone 15 Mg Oral Tablet, Gluconon tablet 15mg, Evogliptin 5mg, SUGANON tablet 5mg

Seung Up Kim

Hepatitis B, Chronic, Fibrosis, Liver, Diabetes Mellitus, Type 2

01/23

02/23

NCT01561586: Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer

Recruiting

374

RoW

Weekly cisplatin with RT, Cisplatin, Tri-weekly cisplatin with RT

Korea Cancer Center Hospital, Seoul National University Hospital, Asan Medical Center, Gangnam Severance Hospital

Cervical Cancer

03/20

03/23

ALSummit, NCT04745299: Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS

Active, not recruiting

115

RoW

Lenzumestrocel, Neuronata-R inj, Autologous Bone Marrow derived Mesenchymal Stem Cell, Riluzole, Rilutek, Placebo Comparator, Normal Saline Inj.

Corestemchemon, Inc.

Amyotrophic Lateral Sclerosis

12/24

05/26

HERIZON-GEA-01, NCT05152147 / 2021-000296-36: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Active, not recruiting

920

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

NCT06493799: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Not yet recruiting

226

LAENNEC (Human Placenta Hydrolysate) IV, LAENNEC (Human Placenta Hydrolysate) SC

Green Cross Wellbeing

Chronic Liver Disease

12/25

MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting

400

Europe, Canada, Japan, US, RoW

tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil

Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC

Colorectal Neoplasms

04/26

07/29

FIRST-308, NCT05948475: Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Recruiting

200

Europe, US, RoW

Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice

TransThera Sciences (Nanjing), Inc.

Cholangiocarcinoma

05/26

08/26

ATLAS, NCT04856982 / 2020-004590-51: A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Active, not recruiting

158

Europe, Canada, Japan, US, RoW

Tofersen, BIIB067, QALSODY, Placebo

Biogen

Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation

08/27

NCT05532124: Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Recruiting

RoW

LAENNEC (Human Placenta Hydrolysate), normal saline

Green Cross Wellbeing

Chronic Liver Disease

03/23

06/23

SGNTUC-019, NCT04579380 / 2020-004873-29: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Active, not recruiting

217

Europe, Japan, US, RoW

tucatinib, TUKYSA, ARRY-380, ONT-380, trastuzumab, Herceptin, fulvestrant, Faslodex

Seagen, a wholly owned subsidiary of Pfizer, Seagen, Inc.

Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast Neoplasms

11/23

05/25

NCT06249854: Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Recruiting

RoW

Bojungikki-tang(BJIKT), Buzhong Yiqi Decoction, Hochu-ekki-to, Pembrolizumab

Korea Institute of Oriental Medicine

Non-small Cell Lung Cancer

12/25

PROCEADE PanTumor, NCT06710132: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors

Recruiting

1/2

250

Japan, US, RoW

M9140, Precemtabart tocentecan

EMD Serono Research & Development Institute, Inc., Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany

Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

01/29

KEYNOTE-G08, NCT05824975: A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors

Recruiting

1/2

358

US, RoW

GI-102 subcutaneous (SC), GI-102, doxorubicin, paclitaxel, bevacizumab, eribulin, trastuzumab deruxtecan (T-DXd), ENHERTU®, pembrolizumab, KEYTRUDA®

GI Innovation, Inc., Merck Sharp & Dohme LLC

Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS), Platinum-resistant Ovarian Cancer (PROC), Hepatocellular Carcinoma (HCC), Colorectal Cancer (CRC), HER2 Negative Breast Cancer, Cutaneous Melanoma, Renal Cell Carcinoma (RCC)

11/25

04/27

NCT06676423: Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

Completed

RoW

Lenzumestrocel, Neuronata-R, Autologous Bone Marrow derived Mesenchymal Stem cell, Riluzole, Rilutek

Corestemchemon, Inc.

Amyotrophic Lateral Sclerosis

11/23

PROCEADE-CRC-01, NCT05464030: Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Recruiting

200

Europe, Canada, Japan, US, RoW

M9140, Precemtabart tocentecan, Bevacizumab, Capecitabine, 5-fluorouracil (5-FU), Folinic acid

EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany

Colorectal Cancer

02/26

KN-8701, NCT04913285: A Study to Evaluate KIN-2787 in Participants with BRAF And/or NRAS Mutation Positive Solid Tumors

Recruiting

400

Europe, US, RoW

KIN-2787, exarafenib, KIN-2787 and binimetinib, exarafenib and binimetinib

Pierre Fabre Medicament

Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma

11/28

03/29

NCT04801095: A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Recruiting

100

RoW

WM-S1-030

Wellmarker Bio, Covance

Advanced Solid Tumor, Metastatic Solid Tumor, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer

08/25

NCT04122833: Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study

Recruiting

N/A

RoW

Next generation sequencing

Konkuk University Medical Center, Roche Diagnostics, Foundation Medicine

Adenocarcinoma of Lung, EGFR Activating Mutation

09/23

12/24

NCT05736341: Comparison of Remimazolam and Midazolam for Preventing Intraoperative Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia

Completed

N/A

RoW

Remimazolam besylate, Midazolam

Yonsei University

Pregnancy, Cesarean Section, Spinal Anesthesia

05/23

01/24

NCT06327165: Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension

Recruiting

N/A

RoW

observation

Yonsei University

Cesarean Section, Spinal Anesthesia

12/24

NCT06886815: Popliteal Nerve Block for Achilles Tendon Repair Surgery

Not yet recruiting

N/A

Canada

Popliteal Nerve Block, Popliteal Sciatic Nerve Block, Sham Block

University of Toronto

Regional Anesthesia, Nerve Block, Achilles Tendon Rupture, Achilles Tendon Surgery

03/27

07/27

NCT04615091: Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Recruiting

N/A

250

Europe, Canada, US, RoW

Azienda Ospedaliera Universitaria Integrata Verona

Advanced Chronic Liver Disease, Surgery--Complications

10/21

08/22

Han, Kwang-Hyub

NCT01937806: Phase 3 and Extensional Study of Besifovir

Active, not recruiting

197

RoW

besifovir 150mg, tenofovir 300mg

IlDong Pharmaceutical Co Ltd

Chronic Hepatitis B

02/16

01/23

Park, Jun Yong

NCT03426904: Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Active, not recruiting

708

RoW

Neoadjuvant FOLFOX, Conventional adjuvant FOLFOX

Kyungpook National University Hospital

Colon Cancer

12/24

12/30

ALKIVIA+, NCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy

Enrolling by invitation

240

Europe, US, RoW

EFG PH20 SC

argenx

Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

09/27

ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Recruiting

2/3

240

Europe, Canada, Japan, US, RoW

EFG PH20 SC, PBO

argenx, argenx BV

Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

12/26

02/27

RELIF-C, NCT02865369: Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Not yet recruiting

N/A

103

RoW

Daclatasvir and Asunaprevir, Daclatasvir and Asunaprevir combined treatment for 24 weeks

Sang Gyune Kim, Seoul National University Boramae Hospital, Severance Hospital, Inha University Hospital, Korea University, Gachon University Gil Medical Center, Hanyang University Seoul Hospital, Ewha Womans University Mokdong Hospital, Bristol-Myers Squibb

Chronic Hepatitis C

12/18

12/22

NCT06093321: A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Recruiting

N/A

RoW

SYB PDO Thread, MINT lift®

Samyang Biopharmaceuticals Corporation

Nasolabial Folds

05/24

02/25

Park, Hana

No trials found

Chon, Young Eun

No trials found

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ahn, Sang Hoon

LONGHEAD, NCT03042520: Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Recruiting

N/A

200

RoW

Observation only

Liver Fibroses, HepatoCellular Carcinoma, Cryoglobulinemia, Metabolic Disease, Diabetes Mellitus

09/22

NCT04139850: The Establishment of Korean Hepatitis B Patients Cohort

Recruiting

N/A

2000

RoW

Discontinuation of antiviral treatment in chronic hepatitis B cohort patients

Yonsei University

Chronic Hepatitis B

08/26

Kim, Do Young

BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting

595

Europe, Canada, Japan, US, RoW

Baricitinib, LY3009104, Placebo

Eli Lilly and Company

Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical

09/27

08/29

NCT05808335: A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

Recruiting

RoW

Standard of care

ImmuneMed, Inc.

Chronic Hepatitis B

03/24

12/24

NCT05908916: Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Not yet recruiting

RoW

AtezoBev with combined radiotherapy

Yonsei University

Hepatocellular Carcinoma

07/25

07/26

IDADOX, NCT06114082: TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

Recruiting

128

RoW

IDA-TACE, Conventional TACE using idarubicin chemoemulsion, DOX-TACE, Conventional TACE using doxorubicin chemoemulsion

Seoul National University Hospital, Guerbet

Hepatocellular Carcinoma, Liver Cancer

12/25

06/26

MIV-818-101, NCT03781934 / 2018-000995-14: A Study to Evaluate MIV-818 in Patients with Liver Cancer Manifestations

Active, not recruiting

1/2

Europe, RoW

MIV-818 (fostroxacitabine bralpamide) + pembrolizumab, MIV-818 (fostroxacitabine bralpamide) + lenvatinib

Medivir

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

01/25

06/25

NCT06712108: Observational Study of Double Cord Blood Transplant

Recruiting

N/A

RoW

tranplant

Seoul National University Hospital

Adult Double Unit Cord Blood Transplant

03/30

HOMECARE, NCT05636384: SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

Recruiting

N/A

396

RoW

Home-based care

Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization

12/26

Kim, Seung Up

NCT04584242: Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Recruiting

RoW

gluconon tab 15mg, suganon tab 5mg

Yonsei University

Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

05/22

NCT05473806: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Active, not recruiting

RoW

Pioglitazone 15 Mg Oral Tablet, Gluconon tablet 15mg, Evogliptin 5mg, SUGANON tablet 5mg

Seung Up Kim

Hepatitis B, Chronic, Fibrosis, Liver, Diabetes Mellitus, Type 2

01/23

02/23

NCT01561586: Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer

Recruiting

374

RoW

Weekly cisplatin with RT, Cisplatin, Tri-weekly cisplatin with RT

Korea Cancer Center Hospital, Seoul National University Hospital, Asan Medical Center, Gangnam Severance Hospital

Cervical Cancer

03/20

03/23

ALSummit, NCT04745299: Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS

Active, not recruiting

115

RoW

Lenzumestrocel, Neuronata-R inj, Autologous Bone Marrow derived Mesenchymal Stem Cell, Riluzole, Rilutek, Placebo Comparator, Normal Saline Inj.

Corestemchemon, Inc.

Amyotrophic Lateral Sclerosis

12/24

05/26

Active, not recruiting

920

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

Not yet recruiting

226

LAENNEC (Human Placenta Hydrolysate) IV, LAENNEC (Human Placenta Hydrolysate) SC

Green Cross Wellbeing

Chronic Liver Disease

12/25

MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting

400

Europe, Canada, Japan, US, RoW

tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil

Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC

Colorectal Neoplasms

04/26

07/29

FIRST-308, NCT05948475: Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Recruiting

200

Europe, US, RoW

Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice

TransThera Sciences (Nanjing), Inc.

Cholangiocarcinoma

05/26

08/26

ATLAS, NCT04856982 / 2020-004590-51: A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Active, not recruiting

158

Europe, Canada, Japan, US, RoW

Tofersen, BIIB067, QALSODY, Placebo

Biogen

Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation

08/27

Recruiting

RoW

LAENNEC (Human Placenta Hydrolysate), normal saline

Green Cross Wellbeing

Chronic Liver Disease

03/23

06/23

SGNTUC-019, NCT04579380 / 2020-004873-29: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Active, not recruiting

217

Europe, Japan, US, RoW

tucatinib, TUKYSA, ARRY-380, ONT-380, trastuzumab, Herceptin, fulvestrant, Faslodex

Seagen, a wholly owned subsidiary of Pfizer, Seagen, Inc.

Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast Neoplasms

11/23

05/25

NCT06249854: Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Recruiting

RoW

Bojungikki-tang(BJIKT), Buzhong Yiqi Decoction, Hochu-ekki-to, Pembrolizumab

Korea Institute of Oriental Medicine

Non-small Cell Lung Cancer

12/25

PROCEADE PanTumor, NCT06710132: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors

Recruiting

1/2

250

Japan, US, RoW

M9140, Precemtabart tocentecan

EMD Serono Research & Development Institute, Inc., Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany

Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

01/29

Recruiting

1/2

358

US, RoW

GI-102 subcutaneous (SC), GI-102, doxorubicin, paclitaxel, bevacizumab, eribulin, trastuzumab deruxtecan (T-DXd), ENHERTU®, pembrolizumab, KEYTRUDA®

GI Innovation, Inc., Merck Sharp & Dohme LLC

11/25

04/27

NCT06676423: Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

Completed

RoW

Lenzumestrocel, Neuronata-R, Autologous Bone Marrow derived Mesenchymal Stem cell, Riluzole, Rilutek

Corestemchemon, Inc.

Amyotrophic Lateral Sclerosis

11/23

PROCEADE-CRC-01, NCT05464030: Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Recruiting

200

Europe, Canada, Japan, US, RoW

M9140, Precemtabart tocentecan, Bevacizumab, Capecitabine, 5-fluorouracil (5-FU), Folinic acid

EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany

Colorectal Cancer

02/26

KN-8701, NCT04913285: A Study to Evaluate KIN-2787 in Participants with BRAF And/or NRAS Mutation Positive Solid Tumors

Recruiting

400

Europe, US, RoW

KIN-2787, exarafenib, KIN-2787 and binimetinib, exarafenib and binimetinib

Pierre Fabre Medicament

Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma

11/28

03/29

NCT04801095: A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Recruiting

100

RoW

WM-S1-030

Wellmarker Bio, Covance

Advanced Solid Tumor, Metastatic Solid Tumor, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Cholangiocarcinoma, Head and Neck Cancer

08/25

NCT04122833: Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study

Recruiting

N/A

RoW

Next generation sequencing

Konkuk University Medical Center, Roche Diagnostics, Foundation Medicine

Adenocarcinoma of Lung, EGFR Activating Mutation

09/23

12/24

NCT05736341: Comparison of Remimazolam and Midazolam for Preventing Intraoperative Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia

Completed

N/A

RoW

Remimazolam besylate, Midazolam

Yonsei University

Pregnancy, Cesarean Section, Spinal Anesthesia

05/23

01/24

NCT06327165: Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension

Recruiting

N/A

RoW

observation

Yonsei University

Cesarean Section, Spinal Anesthesia

12/24

NCT06886815: Popliteal Nerve Block for Achilles Tendon Repair Surgery

Not yet recruiting

N/A

Canada

Popliteal Nerve Block, Popliteal Sciatic Nerve Block, Sham Block

University of Toronto

Regional Anesthesia, Nerve Block, Achilles Tendon Rupture, Achilles Tendon Surgery

03/27

07/27

NCT04615091: Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Recruiting

N/A

250

Europe, Canada, US, RoW

Azienda Ospedaliera Universitaria Integrata Verona

Advanced Chronic Liver Disease, Surgery--Complications

10/21

08/22

Han, Kwang-Hyub

NCT01937806: Phase 3 and Extensional Study of Besifovir

Active, not recruiting

197

RoW

besifovir 150mg, tenofovir 300mg

IlDong Pharmaceutical Co Ltd

Chronic Hepatitis B

02/16

01/23

Park, Jun Yong

NCT03426904: Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Active, not recruiting

708

RoW

Neoadjuvant FOLFOX, Conventional adjuvant FOLFOX

Kyungpook National University Hospital

Colon Cancer

12/24

12/30

ALKIVIA+, NCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy

Enrolling by invitation

240

Europe, US, RoW

EFG PH20 SC

argenx

Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

09/27

ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Recruiting

2/3

240

Europe, Canada, Japan, US, RoW

EFG PH20 SC, PBO

argenx, argenx BV

Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

12/26

02/27

RELIF-C, NCT02865369: Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Not yet recruiting

N/A

103

RoW

Daclatasvir and Asunaprevir, Daclatasvir and Asunaprevir combined treatment for 24 weeks

Chronic Hepatitis C

12/18

12/22

NCT06093321: A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Recruiting

N/A

RoW

SYB PDO Thread, MINT lift®

Samyang Biopharmaceuticals Corporation

Nasolabial Folds

05/24

02/25

Park, Hana

No trials found

Chon, Young Eun

No trials found

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites